Nusantara Sejahtera Raya Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Nusantara Sejahtera Raya Tbk. trades at Rp93 (market cap 7.75T, 8.75M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 51K 24h volume). The key difference: Nusantara Sejahtera Raya Tbk. is far larger — about 46.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Nusantara Sejahtera Raya Tbk. is more actively traded (8.75M versus 51K). Which is the better fit depends on your goals.
| CNMA | OBAT | |
|---|---|---|
Market Cap | 7.75T | 167.37B |
Volume | 8.75M | 51K |
Lot | 87.46K | 510 |
Turnover | 815.8M | 12.55M |
Average Price | 93.28 | 246.09 |
Value | 815.8M | 12.55M |
Indicative Equilibrium Price | 94 | 246 |
Indicative Equilibrium Volume | 1.17K | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Nusantara Sejahtera Raya Tbk. (the “Company”) an Indonesian domiciled company, established on 7 June 1988 by deed of establishment No. 67, drawn up by Benny Kristianto, S.H. The Company commenced its commercial operations in 1989.
Read more on CNMA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →